Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goal-directed furosemide for fluid overload in adult ICU patients
NL-OMON52060Phase 4Recruiting
- Sponsor
- Nordsjællands Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypervolemia comparing Goal-directed furosemide with Matching placebo (2 arms). Primary endpoint: Days alive and out of hospital at day 90. Started Aug 2023; status: recruiting.
02
Drugs
furosemide
03
Conditions
hypervolemia
Beyond the preview
Go deeper on NL-OMON52060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52060.